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 High inter-farm and limited intra-farm M. hyopneumoniae variability was detected  
 One to three M. hyopneumoniae typing profiles were detected within positive farms  
 Same M. hyopneumoniae typing profiles were identified in same breeding origin 
farm  
 
 
Abstract 
This study aimed to describe Mycoplasma hyopneumoniae (M. hyopneumoniae) 
genetic variability in vaccinated (V) and non-vaccinated (NV) slaughtered pigs showing 
cranio-ventral pulmonary consolidation (CVPC). Ten V and 10 NV fattening farms with 
respiratory problems associated to M. hyopneumoniae were selected. Lung lesions of 
one batch per farm were scored at slaughterhouse and the enzootic pneumonia (EP)-
index was calculated. Moreover, three lungs showing the most extensive CVPC per 
farm were sampled and tested for M. hyopneumoniae detection by real-time (rt)-PCR. 
Positive samples with cycle threshold ≤30 were selected to be genotyped by sequencing 
of four loci (P97, P146, H1 and H5). Typing profiles (TP) were assigned considering 
the four or two (P97, P146) loci. Five commercial vaccines for M. hyopneumoniae (VS) 
and two reference strains (RF) were also genotyped. The EP-index (mean±SD) in NV 
farms (3.8±1.9) was not significantly different from V ones (2.2±1.3). From the 60 
selected lungs, 46 (76.7%) were M. hyopneumoniae positive by rt-PCR (25/30 and 
21/30 from NV and V farms, respectively), and 43 (93.5%) of those were successfully 
genotyped. A total of 24 different TP (12 in V and 12 in NV farms) or 17 TP (9 in V 
and 9 in NV farms) were identified by analyzing the four or two loci, respectively. One 
to three TP per farm were detected, being different from VS and RF. Interestingly, 
farms with same breeding origin had the same TP using two loci, but such link was not 
found using four loci. Therefore, high inter-farm and limited intra-farm M. 
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hyopneumoniae genetic variability were detected, but variability depended on the 
number of studied loci. 
Keywords: Mycoplasma hyopneumoniae; genetic variability; lung lesions; vaccination; 
Slaughterhouse 
 
 
 
1. Introduction 
Mycoplasma hyopneumoniae (M. hyopneumoniae) is the primary etiological agent of 
enzootic pneumonia (EP) and plays an important role in porcine respiratory disease 
complex (PRDC) (Maes et al., 2018). M. hyopneumoniae infection mainly affects 
growing and finishing pigs, and is clinically characterized by a non-productive cough 
and causes cranio-ventral pulmonary consolidation (CVPC). The clinical signs and 
lesions cause reduced growth rate and increase feed conversion ratio (Thacker and 
Minion, 2012). Despite all efforts performed to reduce economic losses caused by this 
pathogen, M. hyopneumoniae continues to be an important concern for worldwide swine 
herds (Maes et al., 2018). 
The severity of this respiratory disease depends on the presence of co-infections, 
management and housing conditions, and the virulence of the M. hyopneumoniae strain 
involved in the infection (Vicca et al., 2002, 2003; Maes et al., 2008). Strain genetic 
diversity has been studied using different genotyping techniques such as random 
amplified polymorphic DNA (RAPD; Artiushin and Minion, 1996), amplified fragment 
length polymorphism (AFLP; Kokotovic et al., 1999), pulsed-field gel electrophoresis 
(PFGE; Stakenborg et al., 2005), PCR combined with restricted fragments length 
polymorphism (PCR-RFLP; Stakenborg et al., 2006; Charlebois et al., 2014), individual 
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locus sequencing (Mayor et al., 2007), multi-locus sequencing typing (MLST; Mayor et 
al., 2008) and multiple-locus variable number of tandem repeats (VNTR) analysis 
(MLVA; Vranckx et al., 2011). The importance of these variable VNTR regions relies 
on its capability to recombine (Torres-Cruz and van der Woude, 2003), increasing the 
genomic and proteomic variability of M. hyopneumoniae (Calus et al. 2007; Vranckx et 
al. 2011; Galina-Pantoja et al. 2016). The use of many different techniques covering 
different targets of detection, different power of discrimination and reproducibility has 
complicated the comparison and interpretation of results published to date (Stakenborg 
et al., 2006). However, in the latest peer-reviewed studies, the more frequently used 
techniques are based on MLVA of loci related with adhesion to the host cells (Minion et 
al., 2000; Bogema et al., 2012).  
Up to now, M. hyopneumoniae genetic diversity has been detected at farm, batch, 
pig and even at sample level, with variable inter and intra farm genetic variability 
(Nathues et al., 2011; Vranckx et al., 2012a; Charlebois et al., 2014; Dos Santos et al., 
2015; Michiels et al., 2017a). Variability of M. hyopneumoniae has been studied in 
different scenarios including non-vaccinated (Vranckx et al., 2012a; Overesch et al., 
2017) and vaccinated pigs (Michiels et al., 2017a, Charlebois et al., 2014; Tamiozzo et 
al., 2015), as well as in pigs with unknown vaccination status (Nathues et al., 2011). 
Additionally, some of the M. hyopneumoniae strain used as bacterins have also been 
genotyped (Vranckx et al., 2011; Charlebois et al., 2014; Tamiozzo et al., 2015). 
However, a contemporaneous comparison of M. hyopneumoniae variability between 
non-vaccinated and vaccinated animals, and the strain of the vaccine used in the 
vaccinated farms has not been assessed. Therefore, the aim of the present study was to 
compare, using conventional sequencing of different loci, the M. hyopneumoniae typing 
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profiles (TP) detected in vaccinated and non-vaccinated slaughtered pigs showing 
CVPC lesions, as well as in the vaccines used in such farms.  
 
2. Materials and methods 
2.1 Farm selection 
Ten vaccinated (V) and ten non-vaccinated (NV) fattening farms experiencing clinical 
respiratory signs compatible with M. hyopneumoniae infection (dry cough and presence 
of animals with CVPC in lungs at slaughterhouse) were selected. A fattening farm was 
included as V when pigs were vaccinated against M. hyopneumoniae at weaning. Pigs 
from NV fattening farms did not receive M. hyopneumoniae vaccination at any point in 
the production cycle. Information on farm batch, vaccine products used as well as 
authorization for the slaughter checks were obtained from the practitioner and/or the 
producer. Farms included in the study were located in north-eastern Spain.  
 
2.2 Lung lesion scoring and sample collection at slaughterhouse 
Twenty lung batches (from 10 NV and 10 V farms) of finishing pigs with M. 
hyopneumoniae compatible lung lesions (purple to grey pulmonary consolidation areas, 
generally located bilaterally in the cranio-ventral areas; Maes et al., 2008) were 
individually scored at slaughterhouse. The scoring system used to quantify the M. 
hyopneumoniae-like lung lesions was the Ceva Lung Program (CLP), a lung scoring 
software based on two methods previously described (Christensen et al., 1999; Madec 
and Kobisch, 1982). In the CLP system, each lobe was scored from 0 to 4 points 
according to the following classification: 0) no lesion, 1) lesion affecting <25% of the 
lobe surface, 2) lesion affecting ≥25% to <50% of the lobe surface, 3) lesion affecting 
≥50% to <75% of the lobe surface and 4) lesion affecting ≥75% of the lobe surface 
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(Madec and Kobisch, 1982). Each lobe score was finally normalized by its relative 
volume (Christensen et al., 1999). Moreover, an additional point to the total lung score 
was considered when a scar was present in any lung lobe. The EP-index of each farm 
was calculated as the mean score of all evaluated lungs.  
Three lungs showing the most extensive CVPC lesions within each batch were 
selected for M. hyopneumoniae strain variability detection and characterization. From 
those lungs, a portion of each lobe (including affected and healthy tissue) were collected 
to increase the rate of bacterium detection. Samples were transported in refrigeration to 
the laboratory where they were stored at -80ºC until used.  
 
2.3 Vaccines and reference strains 
Five commercial vaccines (bacterins) against M. hyopneumoniae (A, B, C, D and E) 
used in V farms were included for genotyping. All the vaccine strains (VS) were 
genotyped from its corresponding commercial product, except for the strain coming 
from the vaccine E, which was directly genotyped from a bacterial culture (kindly 
provided by manufacturer E), due to the impossibility of being directly amplified from 
the vaccine product. Moreover, the two reference strains (RF), the strain 11 (ATCC® 
25095™) and the type strain J (ATCC® 25934™), were included in the study as 
controls. In order to test the RF in the same conditions as the strains detected in lung 
samples, different lung tissue portions negative to rt-PCR were spiked with each RF 
culture in vitro and subsequently processed as slaughterhouse lung portions.  
 
2.4 DNA extraction and M. hyopneumoniae detection 
Approximately 1 cm3 including affected and healthy lung tissue from slaughtered pigs 
or the lung portion spiked with M. hyopneumoniae RF strain was homogenized in 
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plastic tubes with 600 μL of PBS and glass beads. These lung homogenates were 
disrupted using TissueLyser (Qiagen GmbH, Germany) by shaking for 10 min and 
centrifuged at 11,000 g for 1 min. After centrifugation, 200 μL of tissue supernatant was 
collected for DNA extraction. Likewise, 200 μL of each vaccine product was directly 
used for extraction.   
DNA extraction from tissue supernatant, vaccines and M. hyopneumoniae culture 
(vaccine E strain) was performed by MagMax™ DNA Multi-Sample Kit (Life 
Technologies, USA) according to the manufacturer’s instructions on the BioSprint 96 
workstation (Qiagen GmbH, Germany). Two different positive extraction controls were 
used: 1) a lung tissue portion spiked with M. hyopneumoniae strain 11 
(ATCC®25095™) was added to each extraction plate; and 2) a commercial internal 
positive control (Xeno™, included in qPCR Master Mix kit, VetMax™-Plus, Life 
Technologies, USA) was added to every tissue sample. Negative controls (PBS) were 
also included to assess potential contamination during extraction. 
Extracted DNA was tested by a commercial real time PCR (rt-PCR) for M. 
hyopneumoniae detection: VetMax™-Plus qPCR Master Mix (Life Technologies, USA) 
with VetMax™ M. hyopneumoniae Reagents (Life Technologies, USA) according to 
the manufacturer’s instructions. A positive DNA control for amplification of M. 
hyopneumoniae (VetMax™ M. hyopneumoniae Controls) was also included in the rt-
PCR procedure. All rt-PCR runs were carried out in ABIPRISM® 7500 machine 
(Applied Biosystems, Singapore). The rt-PCR threshold was set at 10% of the 
maximum fluorescence value of the commercial DNA positive control. Samples with 
cycle threshold (Ct) values lower than 40 were considered positive. Only samples with 
M. hyopneumoniae positive rt-PCR with Ct values ≤30 were selected to be 
characterized by sequencing of different loci (Galina-Pantoja et al., 2016). 
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 2.5 Characterization of M. hyopneumoniae strains  
Characterization of M. hyopneumoniae strains was based on the VNTR count of four 
different loci related with the adhesion: P97 (repeat region 1, RR1), P146 (RR3), H1 
(complete loci) and H5 (RR2; Vranckx et al., 2011). For the genotyping assay, the four 
loci were individually amplified in a final volume of 50 μL. Reaction mixtures 
contained 1X PCR Buffer, 1.5 mM MgCl2, 0.2 mM of each deoxynucleotide 
triphosphate, 0.4 µM of each primer, 1.5 U of GoTaq® G2 Flexi DNA Polymerase 
(Promega, Madison, USA), and finally, 6 µL of extracted DNA diluted 1:10. Cycling 
conditions were 4 min at 94°C, followed by 35 cycles of 30 s at 94°C, 30 s at 53°C and 
30 s at 72°C; then, a final extension step of 7 min at 72°C was performed. 
The PCR products from each locus were analyzed by electrophoresis on 2% 
agarose gel in Tris-Acetate-EDTA (TAE)-buffer and stained with ethidium bromide. 
Afterwards, products were purified by ExoSAP-IT® (Isogen Life Science, The 
Netherlands) according to manufacturer’s instructions and sequenced using ABI PRISM 
3130xl (Applied Biosystems, Singapore) genetic analyzer.  
 
2.6 Data analysis  
Nucleotide sequences were aligned to obtain the consensus sequence obtained using 
FingerPrinting II Informatix software (Applied Maths, Saint-Martens-Latem, Belgium). 
The translation of consensus sequences to protein sequences was performed using the 
Expasy web tool (http://web.expasy.org/translate). Subsequently, VNTR counts per 
locus were performed, according to the following amino acid repetitions: AAKP[EV] 
for P97, S for P146, QTTQ(KD) for H1 and Q for H5 (Vranckx et al., 2011). All 
translated sequences obtained for each loci were first aligned using MUSCLE (v3.8.31) 
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and, then, concatenated to obtain all the loci per sample. Such analysis was performed 
in two different fashions, considering 4 loci, P97-P146-H1-H5 (Michiels et al., 2017a; 
Vranckx et al., 2011), or 2 loci, P97-P146 (Dos Santos et al., 2015; Galina-Pantoja. et 
al., 2016; Takeuti et al., 2017). Afterwards, a TP was defined for each different 
combination of VNTR when 4 (TP4) or 2 loci (TP2) were considered. Minimum 
spanning trees, constructed considering the origin and type of the sample (V and NV 
farms, RF and VS) together with the TP detected, were performed in PHYLOViZ 2.0 
(Ribeiro-Gonçalves et al., 2016).  
 
2.7 Statistical analyses 
Mean of continuous variables (EP-index and mean of Ct rt-PCR values) between NV 
and V farms was compared by unpaired t-test. All statistical analyses were performed 
using GraphPad Prism 6.07 software (GraphPad software Inc., San Diego, USA). The 
significance level was set to p<0.05. 
 
3. Results 
3.1 Lung lesion scoring 
A total of 3,069 lungs were scored with an average (min. – max.) number of lungs 
evaluated per batch of 153 (93 – 212). The EP-index of each batch is shown in Table 1. 
The mean of EP-index (mean ± standard deviation [SD]) in NV farms (3.8±1.9) was 
numerically higher, but not significantly different, than that of V farms (2.2±1.3).  
 
3.2 M. hyopneumoniae detection by rt-PCR 
From the 60 (30 from V and 30 from NV farms) tested lung samples, 46 (76.7%, 25 
from NV and 21 from V herds) were positive by rt-PCR (Table 2). However, there were 
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4 farms (V3, V4, V10 and NV4) with all tested samples negative to rt-PCR and one 
farm (NV5) with only one rt-PCR positive sample. The Ct mean value (±SD) of rt-PCR 
positive lungs from V farms (25.5±2.9) was slightly higher than that of NV farms 
(24.5±3.8), although this difference was not statistically significant. 
The rt-PCR Ct values for the five commercial vaccines against M. hyopneumoniae 
(A, B, C, D and E) and RF are detailed in Table 3. 
3.3. PCR amplification and number of VNTR. 
From the 46 samples that resulted positive by rt-PCR, the 43 (93.5%) having a Ct≤30 
were selected to be genotyped. Although the 4 loci were amplified in 43 samples, in 
only 31 (72.1%) the 4 loci were sequenced appropriately and, therefore, the samples 
were typeable. However, when only 2 loci (P97 and P146) were considered, 38 (38/43, 
88.4%) samples were typeable. Variations with respect to the amino acid sequence of 
the VNTR previously described were detected (i.e. TTKP[EV] instead of AAKP[VE]). 
Such repetition was counted but marked with a star (*) in the final number of repetitions 
of such loci (Table 2).  
Only one TP per sample was detected and one to three TP per farm were identified. 
Considering NV and V farms, different VNTR were identified for each locus, i.e. 7 for 
P97, 10 for P146, 9 for H1, and 11 for H5. The number of repetitions detected in each 
locus ranged between 2 to 12 for P97, 13 to 46 for P146, 2 to 18 for H1 and 13 to 27 for 
H5 (Table 2). 
Considering the four loci, 24 different M. hyopneumoniae TP were identified: 12 in 
NV and 12 in V farms (Table 2). In contrast, when only 2 loci (P97 and P146) were 
considered, 17 different TP were detected, 9 TP in NV and 9 in V farms, because TP2-6 
was present in NV and V farms (Table 2).  
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Regarding VS, vaccine B was considered non-typeable in all four genes due to the 
failure in the amplification of loci P97 and H5. Thus, in the five VS, a total of four 
different TP were identified using either four or two loci (Table 3). As expected, 
detected TP in vaccinated and non-vaccinated pigs were different from the tested VS 
either using four or two loci (except in the case of vaccine E and one of the pigs from 
farm NV6, which had the same TP when only two loci were considered). Likewise, in 
the M. hyopneumoniae RF, one TP was identified in each culture, being different from 
TPs detected in vaccinated pigs and VS, regardless the number of loci considered for 
the analysis. The minimal spanning trees depicting the similarity of the detected TP 
according to four loci (A) and two loci (B) are shown in Figure 1.  
 
4. Discussion 
This study attempted to describe the M. hyopneumoniae genetic variability in lungs 
showing EP compatible lesions from various NV and V Spanish farms. In addition, 
variability was compared with the strain of the vaccine used in each of the V farms, as 
well as with two RF. To reach the goals, previously described regions from four loci 
related with adhesion (Vranckx et al., 2011) were sequenced, VNTR were counted and 
used to define the TP of each strain and the number of TP per farm. 
Although the assessment of the vaccine efficacy was not included in the objective 
of the present study, the differences in EP-index between V and NV farms were 
calculated. Generally, lungs from NV farms showed a numerically higher EP-index 
(more severe lesions) than V farms. The fact that the differences between V and NV 
farms were not statistically significant might be explained by the different disease status 
of evaluated farms, the different vaccines used, the sample size, as well as the potential 
failure or inefficiency of vaccines. Interestingly, V farms with vaccine B (V10) or with 
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vaccine E (V3 and V4) in which M. hyopneumoniae was not detected in the tested 
samples, showed the lowest EP-index. This finding would be in favor of the previously 
suggested capability of vaccines to decrease the bacterial load implying a lung lesion 
reduction (Vranckx et al., 2012b; Woolley et al., 2012; Michiels et al., 2017b). 
However, similar results (no M. hyopneumoniae detection by rt-PCR) were detected in 
farms NV4 and NV5. This can be explained by the fact that the lesions were on a 
resolution phase or were caused by other respiratory pathogens (i.e. swine influenza 
virus; Maes et al., 2008). Therefore, considering that, in this study the presence of other 
CVPC-causing pathogens was not investigated, no definitive conclusions regarding the 
effect of the vaccine on lung lesions reduction can be reached in the farms where M. 
hyopneumoniae was not detected. 
In the present study, only one M. hyopneumoniae TP per sampled lung was able to 
be detected by Sanger sequencing. This result would differ from those previous studies, 
in which MLVA has been used, and in which co-infections with more than one M. 
hyopneumoniae strain (or TP) at pig level were described (Nathues et al., 2011; 
Vranckx et al., 2012a; Charlebois et al., 2014; Michiels et al., 2017a). These divergent 
results could be derived from intrinsic limitations of the different techniques. While the 
observation of different peaks in MLVA informs on the presence of different strains, 
Sanger sequencing most probably identifies the predominant one (Vranckx et al., 2011, 
2012a, Michiels et al., 2017a). Indeed, the effect of multiple strain infection at the level 
of lung lesion is still controversy. Whereas Michiels et al. (2017a) linked the number of 
different strains detected with the severity of lesions, other authors have not observed 
such association (Vranckx et al., 2012a; Charlebois et al., 2014).  
The use of different genotyping techniques influences the number of TP profiles 
obtained and, thus, the conclusions on M. hyopneumoniae genetic variability. In Sanger 
AC
CE
PT
ED
 M
AN
US
CR
IPT
sequences the number of VNTR is visually and directly counted from each sequence per 
locus allowing a clear definition of the obtained TP (unique combination of loci; Falde 
et al., 2018). On the contrary, in MLVA, the number of VNTR is estimated from the 
height of the peak. Therefore, in cases of multiple infections, multiple peaks per loci 
would be obtained, and the exact number of VNTR for each strain would not properly 
ascertained.  
An interesting conclusion from the data is that the number of TP obtained varied 
according to the number of loci used: the higher the number of tested loci, the higher the 
heterogeneity, which is especially evident in the minimum spanning tree. This finding 
would explain the results obtained in previous studies in terms of genetic diversity. 
While high genetic diversity was detected at inter and intra farm level when four loci 
were considered (Nathues et al., 2011; Tamiozzo et al., 2015; Michiels et al., 2017a), a 
limited variability has been detected when only two loci were studied, specially within 
the same herd (Charlebois et al., 2014; Dos Santos et al., 2015; Galina-Pantoja et al., 
2016). In the present study, genotyping with two loci allowed to detect the same TP in 
pigs from farms with the same breeding origin. Although this finding suggests that the 
sows could be the origin of infection (Sibila et al., 2007), when 4 loci were used, such 
link was not found. Thus, the slightly difference on TPs using 4 loci could indicate TPs 
might vary independently during nursery and fattening period.  
The comparison of VNTR between M. hyopneumoniae field samples, VS used in 
each farm, and RF strains revealed different TP. Interestingly, vaccine A had a different 
TP compared to that of RF type strain J, from which is originated. This difference could 
be explained by the effect of serial bacterium passages and/or the inactivation process in 
the case of vaccine manufacturing. Likewise, in agreement with previous studies, a low 
similarity between field strains and VS was also found (Charlebois et al., 2014; 
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Tamiozzo et al., 2015). In fact, TPs detected in V farms were different from the VS of 
corresponding vaccines used in each V farm. It is not known whether this difference 
among field and vaccine TPs implies differences at antigenic level. If this would be the 
case, these differences might potentially explain the variable effect of vaccination 
observed under field conditions (Maes et al., 2008). However, a previous study did not 
detect differences on protective efficacy using homologous or heterologous strains as 
bacterins in experimentally inoculated pigs (Villareal et al., 2012) 
Another important point to be considered for M. hyopneumoniae genotyping is 
locus selection. In the present study, four loci previously used in the literature were 
selected (Vranckx et al., 2011). Among them, the loci most frequently used are the P97 
and P146 (Kuhnert et al., 2011; Nathues et al., 2011; Charlebois et al., 2014; Dos Santos 
et al., 2015; Galina-Pantoja et al., 2016; Takeuti et al., 2017), which encode adhesins 
involved in binding to cilia (Minion et al., 2000; Bogema et al., 2012). The variability 
and ranges of VNTR for these loci were in agreement with the previously described in 
Spanish field isolates (Dos Santos et al., 2015), showing greater variability in P146 than 
in P97. On the contrary, in other countries such as Brazil, Mexico and United States, 
P97 has shown more variability than P146, although the ranges of P146 of Brazilian 
isolates were similar to the Spanish samples (Dos Santos et al., 2015). The other two 
selected loci, H1 and H5, encode for hypothetical proteins related to adhesion (Vranckx 
et al., 2011; Tamiozzo et al., 2015; Michiels et al., 2017a). The use of H1 and H5, from 
which previous information on VNTR was not available, resulted in a high number of 
non-typeable samples. The lack of success for sequencing has been previously 
associated with potential M. hyopneumoniae mutations in primer-binding sites or with 
insufficient DNA quantity or quality (Kuhnert et al., 2011; Vranckx et al., 2011; 
Tamiozzo et al., 2015).  
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In summary, a high inter-farm M. hyopneumoniae genetic variability in slaughtered 
pigs from V and NV Spanish farms was detected. Interestingly, detected TP in V farms 
were different from the strain of the corresponding vaccine used either four or two loci. 
Likewise, the analysis using two loci showed that pigs from farms with the same 
breeding origin harbored the same M. hyopneumoniae TP, but this link was not 
observed if four loci were considered. M. hyopneumoniae diversity at intra-farm level 
was limited and the number of TP detected per farm varied according to the number of 
the loci considered.  
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Figures 
 
 
Figure 1. Minimum spanning tree showing the different M. hyopneumoniae variants profiles detected 
according to four (A) and two (B) loci. Each circle represents one typing profile of M. hyopneumoniae. 
The size of the circle is proportional with the number of samples harboring each typing profile. Absolute 
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distances among typing profiles detected are represented by link label. 
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Table 1. Farm data, percentage (%) of lung lesions with cranio-ventral pulmonary consolidation (CVPC) and enzootic pneumonia (EP)-index ± standard 
deviation (SD) per farm. 
Farm batch 
Non-vaccinated farms Vaccinated farms 
NV1 NV2 NV3 NV4 NV5 NV6 NV7 NV8 NV9 NV10 V1 V2 V3 V4 V5 V6 V7 V8 V9 V10 
Vaccinea - - - - - - - - - - D D E E C C A A B B 
Breeding originb a b c d e f a a g h i i j k L m n o p q 
No. scored lungs 100 93 169 207 212 155 136 203 115 139 102 115 110 128 174 171 203 175 196 166 
% of lungs with 
CVPC 
83 83 76 74 50 72 22 80 80 91 60 79 20 57 65 85 80 57 64 25 
EP-indexc 5.5 4.2 4.4 1.97 1.3 3.5 0.9 4.1 4.7 7.1 2.4 3.4 0.1 0.8 2.7 3.4 3.7 3.1 2.5 0.3 
Mean % of lungs 
with CVPC 
71.1±19.3 59.2±20.6 
Mean EP±SD  3.8±1.9 2.2±1.3 
a Capital letters (A, B, C, D and E) represent commercial vaccines against M. hyopneumoniae available in the Spanish market; ba–q:  Different breeding origin farms; 
CVPC: cranio-ventral pulmonary consolidation; cEP-index: Enzootic pneumonia index was calculated by the Ceva Lung Program (CLP) 
AC
CE
PT
ED
 M
AN
US
CR
IPT
Table 2. Enzootic pneumonia lesion score, mean rt-PCR Ct value, counts of variable number of tandem repeats (VNTR) and 
typing profiles (TP) using 4 and 2 loci from the three non-vaccinated (NV) and vaccinated (V) sampled animals per batch.  
Origin 
Sample 
ID 
Lung lesion 
score 
rt-PCR 
(Ct) 
VNTR  Typing profileb 
P97 P146 H1 H5 4 loci 2 loci 
NV1 
L1a 
L1b 
L1c 
13 
12 
9 
22.7 
22.0 
21.9 
6* 
6* 
6* 
25 
25 
25 
6 
5 
6 
18* 
18* 
16 
TP4-1 
TP4-2 
TP4-3 
TP2-1 
TP2-1 
TP2-1 
NV2 
L2a 
L2b 
L2c 
14 
6 
22 
23.9 
24.7 
23.6 
10 
12 
8 
29 
17* 
35 
5 
7 
- 
15* 
15* 
12* 
TP4-4 
TP4-5 
- 
TP2-2 
TP2-3 
TP2-4 
NV3 
L3a 
L3b 
L3c 
18 
7 
8 
18.6 
23.4 
19.7 
11* 
11* 
9* 
13* 
13* 
13* 
12 
12 
10* 
15* 
15* 
17 
TP4-6 
TP4-6 
TP4-7 
TP2-5 
TP2-5 
TP2-6 
NV4 
L4a 
L4b 
L4c 
5 
3 
1 
Und 
Und 
Und 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
NV5 
L5a 
L5b 
L5c 
1 
2 
3 
37.2 
Und 
Und 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
NV6 
L6a 
L6b 
L6c 
3 
9 
7 
22.6 
22.3 
23.4 
9 
11 
2 
15* 
- 
- 
18 
5 
5 
13* 
14 
- 
TP4-8 
- 
- 
TP2-7 
- 
- 
NV7 
L7a 
L7b 
L7c 
7 
7 
4 
26.1 
25.2  
25.7 
6* 
6* 
6* 
25 
25 
25 
6 
6 
6 
- 
18* 
- 
- 
TP4-1 
- 
TP2-1 
TP2-1 
TP2-1 
NV8 
L8a 
L8b 
L8c 
5 
5 
7 
23.6 
24.2 
23.9 
6* 
6* 
6* 
25 
25 
25 
- 
6 
6 
- 
13 
17 
- 
TP4-9 
TP4-10 
TP2-1 
TP2-1 
TP2-1 
NV9 
L9a 
L9b 
L9c 
7 
4 
17 
24.2 
29.8 
28.8 
10* 
10* 
10* 
13 
13 
13 
4 
4 
4 
13* 
13* 
13* 
TP4-11 
TP4-11 
TP4-11 
TP2-8 
TP2-8 
TP2-8 
NV10 
L10a 
L10b 
L10c 
2 
1 
6 
20.8 
30.3 
23.6 
12 
6* 
6* 
13 
25 
25 
4 
6 
6 
16 
18* 
18* 
TP4-12 
TP4-1 
TP4-1 
TP2-9 
TP2-1 
TP2-1 
V1 
Lv1a 
Lv1b 
Lv1c 
12 
8 
10 
24.6 
29.7 
26.1 
9* 
- 
9* 
13* 
- 
13* 
6 
- 
- 
27 
- 
- 
TP4-13 
- 
- 
TP2-6 
- 
TP2-6 
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V2 
Lv2a 
Lv2b 
Lv2c 
3 
4 
2 
23.8 
23.8 
24.7 
9* 
9* 
9* 
13* 
13* 
13* 
5 
5 
5 
12* 
16* 
16 
TP4-14 
TP4-15 
TP4-15 
TP2-6 
TP2-6 
TP2-6 
V3 
Lv3a 
Lv3b 
Lv3c 
2 
2 
1 
Und 
Und 
Und 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
V4 
Lv4a 
Lv4b 
Lv4c 
3 
1 
1 
Und 
Und 
Und 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
V5 
Lv5a 
Lv5b 
Lv5c 
10 
10 
4 
24.6 
24.7 
23.3 
10* 
10* 
10* 
19 
19 
19 
5 
5 
2 
15* 
13* 
15* 
TP4-16 
TP4-17 
TP4-18 
TP2-10 
TP2-10 
TP2-10 
V6 
Lv6a 
Lv6b 
Lv6c 
6 
10 
4 
25.8 
27.4 
23.2 
2 
- 
2 
30 
- 
29 
7 
- 
7 
13* 
- 
14 
TP4-19 
- 
TP4-20 
TP2-11 
- 
TP2-12 
V7 
Lv7a 
Lv7b 
Lv7c 
6 
16 
7 
25.2 
27.3 
24.9 
8 
8 
8 
45 
46 
46 
7 
- 
11 
21* 
- 
11 
TP4-21 
- 
TP4-22 
TP2-13 
TP2-14 
TP2-14 
V8 
Lv8a 
Lv8b 
Lv8c 
7 
9 
6 
31.2 
28.3 
32.3 
- 
8* 
- 
- 
17 
- 
- 
12 
- 
- 
16* 
- 
- 
TP4-23 
- 
- 
TP2-15 
- 
V9 
Lv9a 
Lv9b 
Lv9c 
10 
7 
8 
22.3 
21.9 
21.3 
9* 
8 
8 
30 
- 
30 
6 
- 
6 
7* 
- 
- 
TP4-24 
- 
- 
TP2-16 
- 
TP2-17 
V10 
Lv10a 
Lv10b 
Lv10c 
2 
1 
2 
Und 
Und 
Und 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
aEP-index: Enzootic pneumonia index calculated by Ceva Lung Program (CLP); bTypeable profile was defined 
for each different combination of VNTR when 4 or 2 loci were considered;* The VNTR of this locus was 
different from the one previously described; Und: Undetermined.
Table 3. Information, values of rt-PCR and VNTR counting and typing profile of strains detected in the 
tested vaccines and reference strains (RF). 
Origin Antigen/strain 
Sample 
ID 
rt-
PCR 
(Ct) 
VNTR Typing profilea 
P97 P146 H1 H5 4 loci 2 loci 
Vaccine 
A 
J VA 16.3 9 7 11 22* TP4-25 TP2-18 
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Ct: Cycle threshold; aTypeable profile was defined for each different combination of VNTR when 4 or 2 
loci were considered *The VNTR of this loci was different from the one previously described. 
 
Vaccine 
B 
11 VB 35.5 - 21 - 13* - - 
Vaccine 
C 
NL 1042 VC 26.8 12 19 17 16* TP4-26 TP2-19 
Vaccine 
D 
P-5722-3 VD 25.6 3 19 17 16* TP4-27 TP2-20 
Vaccine 
E 
BA 2940-99 
VE 39.3 - - - - - - 
Culture 30.2 9 15 3 12* TP4-28 TP2-7 
RF - S11 21.3 14* 21 10 14* TP4-29 TP2-21 
RF - SJ 20.2 9* 14 11 25* TP4-30 TP2-22 
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